Patents Examined by Christopher R. Tate
  • Highly functional cellulose composite
    Patent number: 10080371
    Abstract: A cellulose composite which contains a cellulose and a polysaccharide and which is characterized in that the median diameter of colloidal cellulose composites contained in the cellulose composite is 0.85 ?m or more as measured by a dynamic light scattering method.
    Type: Grant
    Filed: August 10, 2012
    Date of Patent: September 25, 2018
    Assignee: ASAHI KASEI CHEMICALS CORPORATION
    Inventors: Kouichirou Enatsu, Haruko Obata, Naoaki Yamasaki
  • Heat-extracted omentum extracts, compositions, methods of preparing and uses thereof
    Patent number: 10071122
    Abstract: Disclosed herein are compositions including an extract of mammalian omentum wherein the extract is a liquid portion of the mammalian omentum, such as an oil, extracted when the omentum is heated to a temperature of between 210 and 240 degrees Fahrenheit. Also disclosed are methods of making a composition including an extract of mammalian omentum wherein the method includes heating mammalian omentum to a temperature of between 212 degrees Fahrenheit and 225 degrees Fahrenheit, such as 215 degrees Fahrenheit and 220 degrees Fahrenheit. Methods of use of the disclosed extracts and compositions are provided including methods of inducing or enhancing angiogenesis, methods of improving skin quality and methods of promoting hair growth and/or inhibiting hair loss.
    Type: Grant
    Filed: March 25, 2011
    Date of Patent: September 11, 2018
    Assignee: COOPERLABS LIMITED
    Inventors: James A. Greene, Jerad Busch, George Wrape, Jr., Jonathan D. Klein
  • Anti-aging composition for vitalization of retinoic acid receptor that contains mixed extract of Chinese matrimony vine and pine needles as effective component
    Patent number: 10064812
    Abstract: Provided are an anti-aging composition that contains a mixed extract of Chinese matrimony vine and pine needles as an effective component and a method of inhibiting aging of skin. The composition is for an external application to the skin, wherein a mixed extract of Chinese matrimony vine and pine needles, which are the natural ingredients, is contained such that excellent anti-aging or wrinkle improvement effects to the skin can be obtained through the vitalization of a retinoic acid derivative.
    Type: Grant
    Filed: August 19, 2015
    Date of Patent: September 4, 2018
    Assignee: Amorepacific Corporation
    Inventors: Young Gyu Kang, Jun Seong Park, Jee Yeun Kim, Yong Joo Na, Nok Hyun Park, Myeong Hun Yeom, Jun Cheol Cho
  • Composition comprising centipede grass extracts or fractions thereof as active ingredients
    Patent number: 10052358
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating diabetes or dementia, comprising centipede grass (Eremochloa ophiuroides) extracts as an active ingredient. It has been identified from animal tests that the centipede grass extracts, fractions thereof, and active fractions separated from the said fractions effectively regulate blood glucose levels, and inhibit the activity of amyloid-?(A?) which is involved in the formation of amyloid plaques that might cause dementia. Thus, the extracts, the fractions thereof, and the active fractions separated from the said fractions can be effectively used in a composition for preventing and treating diabetes or dementia, in a functional food for preventing or improving diabetes or dementia, and in a pharmaceutical composition or health food for blood glucose regulation.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: August 21, 2018
    Assignee: Korea Atomic Energy Research Institute
    Inventors: Byung Yeoup Chung, Sungbeom Lee, Hyoungwoo Bai, Seung Sik Lee
  • Method for producing ginkgo extracts
    Patent number: 10028986
    Abstract: The present invention relates to an improved multistep method for the production of an extract of Ginkgo biloba leaves for use as a drug.
    Type: Grant
    Filed: January 12, 2015
    Date of Patent: July 24, 2018
    Assignee: Dr. Willmar Schwabe GMBH & Co., KG
    Inventors: Frank Waimer, Steffen Reinhard, Hermann Hauer
  • Composition comprising Retinol, a precursor or a reaction product of it and a plant extract from at least one Chamomilla plant for the treatment of cancer
    Patent number: 10028989
    Abstract: The invention relates to a (i) Vitamin A, a reaction product, a metabolite or a precursor of it and (ii) a plant extract of chamomile or an active component thereof, preferably for use in the treatment of cancer. The inventive composition may be provided as a medicament or a pharmaceutical composition. The at least one Chamomilla plant typically contained in the inventive compositions preferably comprises Matricaria recutita, more preferably fibers tubiformis of Matricaria recutita. Esters of Retinol typically contained in the inventive compositions typically comprise e.g. Retinyl acetate and a plant extract from the plant Matricaria recutita.
    Type: Grant
    Filed: September 9, 2013
    Date of Patent: July 24, 2018
    Assignee: ALPINIA LAUDANUM INSTITUTE OF PHYTOPHARMACEUTICAL SCIENCES AG
    Inventors: Matthias H. Kreuter, Jianying Yam
  • Wipe and methods for improving skin health
    Patent number: 10022308
    Abstract: The present invention relates to methods and products, such as wet wipes and absorbent articles, that are capable of imparting a health benefit when used in the intended fashion. More specifically, the products described herein comprise one or more botanical compounds, which are capable of selectively controlling the balance of flora on the skin. The compounds may enhance the adherence of healthy flora to the surface of skin or mucosa, inhibit the growth of problem flora on or around the skin surface, or inhibit the adherence of problem flora to the surface of skin or mucosa, or any combination thereof.
    Type: Grant
    Filed: August 22, 2014
    Date of Patent: July 17, 2018
    Assignee: Kimberly-Clark Worldwide, Inc.
    Inventors: David William Koenig, Beth A. Lange, Christine L. Schneider
  • Hemostatic preparation containing an extract of golden moss
    Patent number: 10022411
    Abstract: The present invention relates generally to agents and devices for promoting hemostasis and, more particularly, to an extract of a plant-based “Traditional Chinese Medicinal” product and devices incorporating such agents for the delivery thereof to bleeding wounds.
    Type: Grant
    Filed: September 20, 2013
    Date of Patent: July 17, 2018
    Assignee: Ethicon, Inc.
    Inventors: Yi-Lan Wang, Xintian Ming
  • Medium for yeasts
    Patent number: 10023836
    Abstract: In order to provide a culture medium eliminating variation by lot of component concentrations, the present invention provides a culture medium, and preferably a chemical-synthetic culture medium, imparting a proliferation ability to yeast that is equivalent to or greater than that of a YPD culture medium. A culture medium is provided which includes sugars as a carbon source capable of being assimilated by yeast; amino acids as a nitrogen source; vitamins; inositol; zinc ion (Zn2+); potassium ion (K+), and magnesium ion (Mg2+), and in which inositol concentration is between 50 and 10,000 mg/L.
    Type: Grant
    Filed: August 23, 2013
    Date of Patent: July 17, 2018
    Assignees: YAMAGUCHI UNIVERSITY, KOHJIN LIFE SCIENCES CO., LTD.
    Inventor: Rinji Akada
  • Hemostatic preparation containing an extract of golden moss
    Patent number: 10022410
    Abstract: The present invention relates generally to agents and devices for promoting hemostasis and, more particularly, to an extract of a plant-based “Traditional Chinese Medicinal” product and devices incorporating such agents for the delivery thereof to bleeding wounds.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: July 17, 2018
    Assignee: Ethicon, Inc.
    Inventors: Yi-Lan Wang, Xintian Ming
  • Biosensing systems for measurement of lactose
    Patent number: 10024797
    Abstract: Herein disclosed are biosensing systems that measure lactose concentration in a solution.
    Type: Grant
    Filed: November 22, 2011
    Date of Patent: July 17, 2018
    Assignee: Colorado State University Research Foundation
    Inventors: Kenneth F. Reardon, David S. Dandy, Ryan E. Holcomb
  • Personal lubricants
    Patent number: 10016357
    Abstract: Personal lubricants containing royal jelly, a glow powder or xylitol are provided.
    Type: Grant
    Filed: March 22, 2013
    Date of Patent: July 10, 2018
    Assignee: THE BEAUTY FACTORY, LLC
    Inventors: Louis J. Rivers, IV, Kevin Stranen
  • Combinations of extracts of serenoa repens and lipophilic extracts of zingiber officinalis and echinacea angustifolia, the use thereof, and formulations containing them
    Patent number: 10016478
    Abstract: Disclosed are compositions containing an extract of Serenoa repens, a lipophilic extract of Zingiber officinalis and a lipophilic extract of Echinacea angustifolia or Zanthoxylum bungeanum.
    Type: Grant
    Filed: June 19, 2017
    Date of Patent: July 10, 2018
    Assignee: Indena S.P.A.
    Inventors: Ezio Bombardelli, Paolo Morazzoni
  • Biomaterials for delivery of blood extracts and methods of using same
    Patent number: 10016505
    Abstract: The disclosure provides biomaterials including scaffolds that include blood products including blood fractions and products including platelets for administration to subjects in need thereof. More specifically, the scaffolds based on step growth polymers are enriched with blood extracts that contain platelet rich plasma (PRP) and/or extracts of platelets. Compositions comprising a biomaterial or precursor thereof and a blood extract are provided, as are methods of making and using the biopolymers or precursors thereof. Kits and articles of manufacture comprising the biopolymers or precursors thereof are also described.
    Type: Grant
    Filed: February 4, 2013
    Date of Patent: July 10, 2018
    Assignee: MOSAIC BIOSCIENCES, INC.
    Inventors: Peter D. Mariner, Martin Stanton, Alexei Kazantsev, Jeanne Callan
  • Biologic prosthesis and methods of production and use
    Patent number: 10016528
    Abstract: Products, processes, compositions, kits, and methods are provided for cartilage-derived implants. The implants can exhibit resistance to enzyme (e.g., collagenase, protease, etc.) digestion compared to the source tissue from which they were derived while still having one or more mechanical properties comparable to the source tissue from which they were derived. The implants can also have a plurality of molecular bridges between molecules of the cartilaginous material. The molecular bridges can connect one or more collagen fibrils and/or/with one or more glycosaminoglycans. The implants can also be treated with cationic detergent, packaged and sterilized with or without additional components, and surgically implanted into subjects.
    Type: Grant
    Filed: September 4, 2014
    Date of Patent: July 10, 2018
    Inventor: Eran Rosines
  • Compositions, uses and methods for making them
    Patent number: 10016360
    Abstract: Disclosed are compositions containing chemical constituents from plants, uses of these compositions and methods for making them. In various embodiments, the present invention relates to an improved modes of administration of herbal remedies.
    Type: Grant
    Filed: July 28, 2014
    Date of Patent: July 10, 2018
    Inventors: Steven Elbogen, Don Wirtshafter
  • Natural composition
    Patent number: 10016477
    Abstract: A medicinal compound includes ingredients combined in proportions substantially including: a portion of Turraea Heterophylla; a portion of Ginger; a portion of Carrot; providing a powdered portion of Celery; a portion of Parsley; and a portion of Pepper. The medicinal compound for both men and women has all natural ingredients designed to increase drive and stamina to provide consenting adults with a product that enhances their sensual activities without the side effects of pharmaceuticals.
    Type: Grant
    Filed: January 10, 2016
    Date of Patent: July 10, 2018
    Inventor: Roger Yomba Ngue
  • Amniotic membrane hydrogel and methods of making
    Patent number: 10016464
    Abstract: The present invention provides compositions and methods for wound healing and tissue regeneration. The compositions of the present invention comprise amniotic membrane of the placenta. In certain embodiments, the composition comprises amniotic membrane powder or solubilized amniotic membrane (SAM). In some aspects, the composition is cell-free and rich in cytokines, extracellular matrix proteins, and other components that improve tissue regeneration. In one aspect, the composition is a hydrogel scaffold that comprises amniotic membrane. The present invention reduces contraction and improves blood vessel development in regenerating tissue.
    Type: Grant
    Filed: August 1, 2014
    Date of Patent: July 10, 2018
    Assignee: Wake Forest University Health Sciences
    Inventors: Sean V. Murphy, Aleksander Skardal, Anthony Atala
  • Methods of reducing skin inflammation using compositions comprising Ampelopsis grossedentata and Albizia julibrissin extracts
    Patent number: 10004677
    Abstract: A composition for applying to skin in need of treatment for skin barrier restoration, hydration and moisturization, the composition comprising extracts of Ampelopsis grossedentata and Albizia julibrissin. Also provided are methods for treating skin in need of skin barrier treatment, methods of treating skin to reduce the signs of aging and methods of treating skin to reduce the signs of inflammation with a composition comprising extracts of Ampelopsis grossedentata and Albizia julibrissin.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: June 26, 2018
    Assignee: Johnson & Johnson Consumer Inc.
    Inventors: Hua Du, Yan Li, Tao Liu, Yingxin Ma
  • Inhibition of hypoxia-inducible factor activity with carica papaya extracts
    Patent number: 10004775
    Abstract: An extract of Carica papaya leaves obtained from a plant of age six months and younger from the date of germination of the seed is used as an inhibitor of HIF to effectively block hypoxia-inducible factor (HIF) function and methods of use thereof. More specifically it relates to the use of the Carica papaya plant extract to eliminate unwanted cells by inhibiting HIF in the prevention and treatment of hypoxia-related conditions and diseases such as inflammatory diseases, vascular diseases, cancer and infectious diseases. In a particular embodiment, a solid hypoxic tumor in a patient is treated by administering to the patient a therapeutically acceptable amount of an extract of Carica papaya leaves obtained from a plant of age six months and younger from the date of germination of the seed, preferably an alcohol extract such as a methanol extract, whereby to inhibit hypoxia-inducible factors in the tumor.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: June 26, 2018
    Assignees: The Regents of the University of California, Universiti Putra Malaysia
    Inventors: Eric J. Stanbridge, Norazizah Shafee, Khatijah Yusoff